The global Vaccines Market is estimated to be valued at USD 54.50 billion in 2025 and is projected to reach USD 111.3 billion ...

The In Situ Hybridization market presents robust growth opportunities driven by rising cancer prevalence, demand for personalized medicine, and technological advancements. However, high operational ...

"I think the common thread is probably that there's a person that's been victimized or discarded or forgotten about by a ...

Meta's (NASDAQ:META) top boss, Mark Zuckerberg, is expected to appear as a key witness in an $8B trial this week, which ...

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

This is an audio transcript of the FT News Briefing podcast episode: ‘Big Pharma markets left in a ‘patent cliff’-hanger’ ...

Delaware has long punched above its weight in science and technology. With a legacy built on industry-defining ...

A son of notorious Mexican drug kingpin “El Chapo,” is expected to plead guilty to U.S. drug trafficking charges ...

The White House calls it "The Trump Effect" and features a rolling list on its website of more than 70 projects it says Trump ...

Merck & Co., Inc. (NYSE: MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention ...

RFK Jr.’s vaccine advisory board could stop recommending some routine childhood immunizations, leaving insurers to decide ...